BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 8272873)

  • 1. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
    Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors.
    Boulton TG; Stahl N; Yancopoulos GD
    J Biol Chem; 1994 Apr; 269(15):11648-55. PubMed ID: 7512571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.
    Davis S; Aldrich TH; Stahl N; Pan L; Taga T; Kishimoto T; Ip NY; Yancopoulos GD
    Science; 1993 Jun; 260(5115):1805-8. PubMed ID: 8390097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling of type II oncostatin M receptor.
    Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
    Ito Y; Yamamoto M; Li M; Doyu M; Tanaka F; Mutch T; Mitsuma T; Sobue G
    Brain Res; 1998 May; 793(1-2):321-7. PubMed ID: 9630704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.
    Bonni A; Sun Y; Nadal-Vicens M; Bhatt A; Frank DA; Rozovsky I; Stahl N; Yancopoulos GD; Greenberg ME
    Science; 1997 Oct; 278(5337):477-83. PubMed ID: 9334309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
    Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
    Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
    Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soluble interleukin-6 receptor.
    Rose-John S; Ehlers M; Grötzinger J; Müllberg J
    Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
    Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
    Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
    J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
    Di Marco A; Gloaguen I; Demartis A; Saggio I; Graziani R; Paonessa G; Laufer R
    J Biol Chem; 1997 Sep; 272(37):23069-75. PubMed ID: 9287306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.
    Habecker BA; Symes AJ; Stahl N; Francis NJ; Economides A; Fink JS; Yancopoulos GD; Landis SC
    J Biol Chem; 1997 Nov; 272(48):30421-8. PubMed ID: 9374533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.